Combo immunotherapy may herald new standard of care for kidney cancer – Medical Xpress
|
Combo immunotherapy may herald new standard of care for kidney cancer
Medical Xpress Combination immunotherapy with nivolumab and ipilimumab as tested in the kidney cancer study described here is already FDA-approved for treatment of melanoma, and is being tested for other cancers. The Kidney Cancer Program at UTSW is one of two … |
